Literature DB >> 797084

Pindolol once daily in the treatment of hypertension.

G Frithz.   

Abstract

The beta-adrenergic blocking drug pindolol has been used in the treatment of hypertension, using one single dose per day, given in the morning. 16 patients with mild to moderate hypertension were treated with doses which were increased if necessary up to 20 mg, and 14 patients achieved an adequate level of blood-pressure control. The trial was carried out as a single-blind cross-over study. The study shows that pindolol, a non-selective beta-blocker of high potency, may be given once daily as a hypotensive, offering advantages both for patients and physicians. Side-effects were infrequent.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 797084     DOI: 10.3109/03009737609179040

Source DB:  PubMed          Journal:  Ups J Med Sci        ISSN: 0300-9734            Impact factor:   2.384


  3 in total

1.  Initiation of once-daily pindolol treatment.

Authors:  G Frithz
Journal:  Br Med J       Date:  1978-02-04

2.  Controlled study of the bronchoconstriction effect of pindolol administered intravenously or orally to patients with unstable asthma.

Authors:  K Mattson; H Poppius
Journal:  Eur J Clin Pharmacol       Date:  1978-11-16       Impact factor: 2.953

3.  Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.

Authors:  J S Floras; J V Jones; M O Hassan; P Sleight
Journal:  Br Med J (Clin Res Ed)       Date:  1982-11-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.